Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma

PURPOSE: To develop a nomogram that estimates 1-year recurrence-free survival (RFS) after trimodality therapy for esophageal adenocarcinoma and to assess the overall survival (OS) benefit of esophagectomy after chemoradiotherapy (CRT) on the basis of 1-year recurrence risk. METHODS: In total, 568 co...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Goense, Lucas, van Rossum, Peter S. N., Xi, Mian, Maru, Dipen M., Carter, Brett W., Meijer, Gert J., Ho, Linus, van Hillegersberg, Richard, Hofstetter, Wayne L., Lin, Steven H.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2018
Assuntos:
Gastrointestinal Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928173/
https://ncbi.nlm.nih.gov/pubmed/29569125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-018-6435-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados